CBIH
Cannabis Bioscience International Holdings, Inc.
Key Financials
Operating Income
$-421365
↑ 13.3%
Net Income
$-548820
↑ 15.7%
Gross Profit
$262916
↑ 29.4%
Total Assets
$31880.00
↓ 44.2%
Total Liabilities
$1.2M
↑ 5.2%
Revenue
$303022
↑ 21.8%
Shareholders' Equity
$-1163583.00
↓ 7.8%
EPS (Diluted)
$-0.00
↑ 16.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 253G2 | 7/1/2026 | View on SEC |
| 253G2 | 5/21/2026 | View on SEC |
| 144 | 5/11/2026 | View on SEC |
| 10-Q | 4/16/2026 | View on SEC |
| 253G2 | 4/15/2026 | View on SEC |
| NT 10-Q | 4/14/2026 | View on SEC |
| QUALIF | 4/13/2026 | View on SEC |
| CORRESP | 4/8/2026 | View on SEC |
| UPLOAD | 4/1/2026 | View on SEC |
| 1-A | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CBIH |
| Company Name | Cannabis Bioscience International Holdings, Inc. |
| CIK | 1411057 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| State of Incorporation | CO |
| Phone | 214-733-0868 |